E2F2 and pheochromocytoma-paraganglioma: Heterozygous deletions of UBB and TP53 in OV; MOV10, AGO1, AGO3, AGO4, CDKN2C, E2F3, MDM4, TP53, UBB, and E2F2 in KICH; TNRC6B in OV and MESO; E2F2 in CHOL; RB1, ETS1, and TFDP1 in TGCT; TP53 and UBB in UCS; TNRC6C in KICH; MOV10 and CDKN2C in Pheochromocytoma and Paraganglioma (PCPG); and MAPK1 in MESO were also all greater than 70% (Figure 7D).